Clonal Relatedness among Imipenem-Resistant Pseudomonas aeruginosa Isolated from ICU-Hospitalized Patients

Critical Care Research and Practice
Hamid VaezHajieh Ghasemian Safaei

Abstract

Imipenem-resistant Pseudomonas aeruginosa (P. aeruginosa) has become an increasingly important problem in healthcare settings worldwide. The aim of the present study was to evaluate clonal spread among imipenem-resistant P. aeruginosa isolated from ICU-hospitalized patients. Totally, 150 wound specimens were analyzed. Antibiotic resistance profiles and clonal diversity were evaluated using Kirby-Bauer's disk diffusion method and Random Amplified Polymorphic DNA- (RAPD-) PCR, respectively. The isolates showed a high frequency of antibiotic resistance against meropenem, and imipenem (100%) followed by ciprofloxacin, and ceftazidime (90%); meanwhile resistance to polymyxin B was not observed. Eighteen (40%) of P. aeruginosa isolates were MBL-positive via ethylenediaminetetraacetic acid (EDTA) combined disk test. Our findings showed high genetic diversity, with 37 different RAPD types detected. RAPD typing results showed cross-acquisition of P. aeruginosa in investigated hospital, suggesting failure in infection control practices. Incidence of MBL-positive isolates is high and should be regarded as a threat to hospitalized patients.

References

Apr 12, 2002·Journal of Microbiological Methods·Shula L DawsonBrian N Dancer
Nov 8, 2003·Journal of Clinical Microbiology·Lucie OntenienteGilles Vergnaud
Dec 8, 2004·Journal of Clinical Microbiology·Barry CurranChristopher G Dowson
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Valerie AloushYehuda Carmeli
Jun 28, 2008·Scandinavian Journal of Infectious Diseases·Marcus ErlandssonHåkan Hanberger
Dec 20, 2008·International Journal of Antimicrobial Agents·Helen C Maltezou
Sep 10, 2009·Antimicrobial Agents and Chemotherapy·José-Manuel Rodríguez-MartínezPatrice Nordmann
Mar 31, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Keiko SaitouMasafumi Fukuyama
Jun 15, 2011·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Ana Claudia Souza RodriguesMarise Dutra Asensi
Sep 11, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P D CroughsUNKNOWN Antibiotic Resistance Surveillance Group
Jun 14, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sónia Gonçalves PereiraOlga Cardoso
Jun 19, 2013·Burns : Journal of the International Society for Burn Injuries·Fatemeh NanvazadehNajmeh Parhizgari
Oct 23, 2013·Annals of Clinical Microbiology and Antimicrobials·Bamidele T OdumosuRam Chandra
Jan 7, 2014·The Australasian Medical Journal·Arunava KaliSivaraman Umadevi
Aug 7, 2014·Journal of Natural Science, Biology, and Medicine·Kolhal Veerappa Yogeesha BabuArun Kumar
Aug 16, 2014·International Journal of Medical Microbiology : IJMM·Lívia V SilvaAndré L S Santos

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
genotyping

Software Mentioned

TreeView
FreeTree

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.